A Study to Assess Adverse Events and Change in Disease Activity of Intramuscular AGN-151586 Injection in Adult Participants With Glabellar Lines
NCT05248867
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
638
Enrollment
INDUSTRY
Sponsor class
Conditions
Glabellar Lines
Interventions
DRUG:
Placebo
DRUG:
AGN-151586
Sponsor
AbbVie